Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno García

Showing results (51-60 of 134) with videos related to

Pageof 14
Sort By:
The American Journal of Cardiology|August 30, 2011
Prognostic value of an abnormal ankle-brachial index in patients receiving drug-eluting stentsAida Ribera, Ignacio Ferreira-González, Josep Ramón Marsal, et al.
JACC. Cardiovascular Imaging|June 17, 2019
Prognostic Value of Initial Left Ventricular Remodeling in Patients With Reperfused STEMIJose F Rodriguez-Palomares, Jose Gavara, Ignacio Ferreira-González, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 25, 2017
The impact of waiting for intervention on costs and effectiveness: the case of transcatheter aortic valve replacementAida Ribera, John Slof, Ignacio Ferreira-González, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 28, 2022
Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trialLuis Ortega-Paz, Salvatore Brugaletta, Josep Gomez-Lara, et al.
Circulation|September 26, 2019
Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical TrialManel Sabaté, Fernando Alfonso, Angel Cequier, et al.
Respirology (Carlton, Vic.)|October 27, 2023
EBUS-TBNA for mediastinal staging of centrally located T1N0M0 non-small cell lung cancer clinically staged with PET/CTPere Serra Mitjà, Bruno García-Cabo, Ignasi Garcia-Olivé, et al.
Arquivos Brasileiros De Cardiologia|September 8, 2022
Adjusting RFR by Predictors of Disagreement, "The Adjusted RFR": An Alternative Methodology to Improve the Diagnostic Capacity of Coronary IndicesDiego Fernández-Rodríguez, Juan Casanova-Sandoval, Ignacio Barriuso, et al.
International Journal of Cardiology|July 12, 2011
Drug-eluting stents for off-label indications in real clinical world: evidence based or 'intuition' based clinical practice?Aida Ribera, Ignacio Ferreira-González, Bruno García Del Blanco, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 23, 2014
Rationale and design of the RIBS IV randomised clinical trial (drug-eluting balloons versus everolimus-eluting stents for patients with drug-eluting stent restenosis)Fernando Alfonso, María José Pérez-Vizcayno, Alberto Cárdenas, et al.
JACC. Cardiovascular Interventions|June 25, 2016
Long-Term Results of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients With Bare-Metal In-Stent Restenosis: 3-Year Follow-Up of the RIBS V Clinical TrialFernando Alfonso, María José Pérez-Vizcayno, Bruno García Del Blanco, et al.
Pageof 14

Showing results (51-60 of 134) with videos related to

Sort By:
Pageof 14
The American Journal of Cardiology|August 30, 2011
Prognostic value of an abnormal ankle-brachial index in patients receiving drug-eluting stentsAida Ribera, Ignacio Ferreira-González, Josep Ramón Marsal, et al.
JACC. Cardiovascular Imaging|June 17, 2019
Prognostic Value of Initial Left Ventricular Remodeling in Patients With Reperfused STEMIJose F Rodriguez-Palomares, Jose Gavara, Ignacio Ferreira-González, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 25, 2017
The impact of waiting for intervention on costs and effectiveness: the case of transcatheter aortic valve replacementAida Ribera, John Slof, Ignacio Ferreira-González, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 28, 2022
Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trialLuis Ortega-Paz, Salvatore Brugaletta, Josep Gomez-Lara, et al.
Circulation|September 26, 2019
Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical TrialManel Sabaté, Fernando Alfonso, Angel Cequier, et al.
Respirology (Carlton, Vic.)|October 27, 2023
EBUS-TBNA for mediastinal staging of centrally located T1N0M0 non-small cell lung cancer clinically staged with PET/CTPere Serra Mitjà, Bruno García-Cabo, Ignasi Garcia-Olivé, et al.
Arquivos Brasileiros De Cardiologia|September 8, 2022
Adjusting RFR by Predictors of Disagreement, "The Adjusted RFR": An Alternative Methodology to Improve the Diagnostic Capacity of Coronary IndicesDiego Fernández-Rodríguez, Juan Casanova-Sandoval, Ignacio Barriuso, et al.
International Journal of Cardiology|July 12, 2011
Drug-eluting stents for off-label indications in real clinical world: evidence based or 'intuition' based clinical practice?Aida Ribera, Ignacio Ferreira-González, Bruno García Del Blanco, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 23, 2014
Rationale and design of the RIBS IV randomised clinical trial (drug-eluting balloons versus everolimus-eluting stents for patients with drug-eluting stent restenosis)Fernando Alfonso, María José Pérez-Vizcayno, Alberto Cárdenas, et al.
JACC. Cardiovascular Interventions|June 25, 2016
Long-Term Results of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients With Bare-Metal In-Stent Restenosis: 3-Year Follow-Up of the RIBS V Clinical TrialFernando Alfonso, María José Pérez-Vizcayno, Bruno García Del Blanco, et al.
Pageof 14